From: Impact of kinesin Eg5 inhibition by 3,4-dihydropyrimidin-2(1H)-one derivatives on various breast cancer cell features
Compound
IC50(μM)
Maximum non-cytotoxic concentration to normal cells (mM)
MCF-7
MDA-MB-231
4 m
197.3
77.08
1.0
4bt
126.9
17.91
0.8
4p
87.5
68.38
0.4
4bc
234.9
249.5
4x
276.5
237.4
Monastrol
110.4
113.9